|
Follow the links below to information on Creutzfeldt Jakob Disease (CJD) and variant CJD (vCJD) as well as other prion diseases such as Bovine Spongiform Encephalitis (BSE) and Transmissible Spongiform Encephalopathies (TSEs)
Reviewed May 2008
Printer friendly page
| Results 1 to 15 displayed. |
| Title: |
Creutzfeldt-Jakob disease
|
| Publisher: |
Better Health Channel
|
| Description: |
Creutzfeldt-Jakob disease (CJD) is a rapidly progressive disease that causes deterioration of the brain. It is one of a group of rare diseases that affects humans and animals. There is no cure and death usually results within two years of the symptoms first appearing. Variant CJD is sometimes referred to as 'mad cow disease'.
|
| Date: |
Sep 2007
|
| Title: |
Creutzfeldt-Jakob disease
|
| Publisher: |
myDr
|
| Description: |
Creutzfeldt-Jakob disease (CJD) is a degenerative brain disorder that causes rapidly progressive dementia. There are 2 main types of CJD - classical and variant.
|
| Date: |
Jun 2006
|
| Title: |
Frequently asked questions
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
This page contains questions and answers about bovine spongiform encephalopathy (BSE) in animals and its links with variant Creutzfeldt-Jakob disease (vCJD) in humans.
|
| Date: |
Dec 2004
|
| Title: |
Mad cow disease
|
| Publisher: |
Healthy Eating Club
|
| Description: |
Bovine Spongiform Encephalopathy (BSE) or 'Mad Cow Disease' as it is more commonly known, is a chronic degenerative disease that affects the central nervous system of cattle over two years old.
|
| Date: |
Apr 2001
|
| Title: |
Australia's Health Response
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
This page contains details of measures taken by the Australian Government to protect human health in response to bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD).
|
| Date: |
Dec 2004
|
| Title: |
Pituitary hormones initiatives
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
This page contains information on the relation between human pituitary hormone treatment and Creutzfeldt-Jakob disease (CJD) as well as Government's initiatives for the control and prevention of CJD.
|
| Date: |
Nov 2007
|
| Title: |
Creutzfeldt - Jakob Disease
|
| Publisher: |
Queensland Health
|
| Description: |
Creutzfeldt - Jakob disease (CJD) is a very rare disease that affects brain tissue in humans. When people first start to show symptoms, they usually present with confusion, disorientation and problems with walking. Death can occur up to two years after a person shows the first symptoms; however, most people die within six months. There is no treatment or cure.
|
| Date: |
Feb 2007
|
| Title: |
Creutzfeldt-Jakob disease - fact sheet
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
Creutzfeldt-Jakob disease (CJD) is a rapidly progressive disease causing damage to the brain. It is one of a group of rare diseases that affects humans and animals, known as the transmissible spongiform encephalopathies or prion diseases. Creutzfeldt-Jakob disease is characterised by dementia and walking difficulties.
|
| Date: |
Sep 2004
|
| Title: |
Growth hormone
|
| Publisher: |
Better Health Channel
|
| Description: |
The pituitary gland of the brain produces growth hormone, which governs height, bone length and muscle growth. Some people take synthetic growth hormone in the mistaken belief it will help them build muscle size and strength.
|
| Date: |
Mar 2007
|
| Title: |
Transmissible Spongiform Encephalopathies (TSEs) questionnaire for sponsors
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
This questionnaire has been designed by the TGA in consultation with Australian industry bodies to facilitate the collection of data to enable Sponsors to self-certify their therapeutic goods against the TGA's 'Supplementary requirements for therapeutic goods for minimising the risk of transmitting transmissible spongiform encephalopathies (TSE)'.
|
| Date: |
Dec 2004
|
| Results 1 to 15 displayed. |
|